PALTC23 Conference Recordings FR26 Riding the D2D Bandwagon for Behavior Change in a PALTC Organization

Riding the D2D Bandwagon for Behavior Change in a PALTC Organization

Since 2021, AMDA has led the nationwide Drive to Deprescribe (D2D) campaign to motivate clinicians to address polypharmacy and medication optimization in the PALTC. This unique campaign has provided interprofessional teams the knowledge, tools, and implementation strategies to address polypharmacy issues. More importantly, the D2D team, as cheerleaders, have sustained a focus on this key issue and solutions to address it. In this interprofessional session, a geriatrician, and a pharmacy leader will share how they used the D2D campaign to create energy to design new interprofessional processes in a large organization and how that impacted care.

Learning Objectives:

At the completion of this session, learners will be able to:

  • Describe hazards of polypharmacy for staff in PALTC.
  • List several D2D strategies for meaningful medication optimization in PALTC.
  • Describe an innovative pharmacist and practitioner partnership model for medication optimization in PALTC.
  • Evaluate the success of an innovative process to address polypharmacy in PALTC.

Rebecca Wingate, PharmD

Rebecca Wingate, PharmD, is the Director of Clinical Operations, North for PharMerica. She lives in Land O Lakes, Florida, and has been actively engaged in expanding PharMerica’s clinical services since 2007. She leads a team of Clinical Operations Managers and Consultant Pharmacists in 28 Northern US states that care for individuals, patients, and residents across various health care settings. Rebecca is committed to embracing technology and innovation toward improving quality clinical services. Her focus prioritizes medication safety, regulatory and clinical compliance, meaningful de-prescribing, and positive patient outcomes.

Arif Nazir, MD, CMD

Arif Nazir, MD, CMD, currently serves as the Chief Medical Officer for BrightSpring Health Services, Primary Care, a large, value-based, geriatric practitioner organization, and the Chief Medical Officer for Signature HealthCARE. He is Past President for AMDA, founding member for the Society’s Innovation Council, and Co-chair of Society’s Drive to Deprescribe initiative. As a healthcare leader, researcher, entrepreneur, and an implementation champion, he continues to focus his efforts on finding practical solutions for solving care coordination gaps and on enhancing leadership and teamwork in the PALTC frontlines.

  • 1.0 CME
  • 1.0 CMD Management
  • 1.0 MOC
  • 1.0 Pharmacology Hour


Release Date: 03/29/2023   |   Expiration: 03/01/2026

Credit Statements:

Accreditation: Post-Acute and Long-Term Care Medical Association is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. 

CME Designation: Post-Acute and Long-Term Care Medical Association designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

CMD Credit Hours: This CME activity has been pre-approved by the American Board of Post-Acute and Long-Term Care Medicine (ABPLM) for up to 1.0 management hour(s) toward certification or recertification as a Certified Medical Director (CMD) in post-acute and long-term care medicine. Each physician should claim only those hours of credit actually spent on the activity.

The CMD Program is administered by the ABPLM. For further information, contact ABPLM at 410-992-3117 or at cmd@paltc.org.

ABIM Maintenance of Certification (MOC): Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 Medical Knowledge MOC points and patient safety credit in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program.

Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Pharmacology: This activity satisfies the requirements for 1.0 Pharmacology Hour(s) for Nurse Practitioners.

Financial Disclosure Statement:

The Association requires the disclosure of all speaker/faculty/planner’s relevant financial relationships; presence of off-label use of a device or medication; and discussion of any experimental, new or evolving topic prior to each accredited education activity.

If the learner perceives any bias toward a commercial product or service, advocation of unscientific approaches to diagnosis or therapy, or recommendation, treatment, or manners of practicing healthcare that are determined to have risks or dangers that outweigh the benefits or are known to be ineffective in the treatment of patients please report this to the Association's staff.


The following speaker(s) disclosed relevant financial relationship(s): 

  • Julie Gammack, MD, CMD (Planner & Speaker): Stockholder: Amarin
  • Kenya Rivas Velasquez, MD, CMD, FAAFP (Planner & Speaker): OptumRx: Stockholder
  • All other planners, speakers, and AMDA staff have no relationships with ineligible companies.

All relevant financial relationships have been identified and mitigated.

Components visible upon registration.